Professor
Université de Montréal, Canada
Dre Bérard has cross-training in epidemiology, pharmacoepidemiology, and genetics from McGill University, Harvard Medical School, and Stanford University. She is full professor of perinatal epidemiology at the University of Montreal, Faculty of Pharmacy, and CHU Ste-Justine in Montreal; and adjunct professor at the Faculty of Medicine of the Université Claude Bernard in Lyon, France. Dr Bérard holds a Canada Research Chair Tier 1 on Medications and Pregnancy; and University of Montreal’s Louis-Boivin research chair on « Medications, pregnancy and lactation ». Anick Bérard is also Director of the Research Unit on Medications and Pregnancy at CHU Ste-Justine; Director of the FRQS Réseau Québécois de recherche sur les médicaments; Fellow of the Canadian Academy of Health Science, and of the International Society of Pharmacoepidemiology; and a voting member of the Birth Defects Research Society. Anick Bérard is the principal investigator of the i) pan-canadian CONCEPTION study – COVID-19 and pregnancy (www.etudeCONCEPTIONstudy.ca), ii) Quebec Pregnancy-Child Cohort, iii) Canadian Mother-Child Active Surveillance Initiative (CAMCCO Research/Training/Knowledge Dissemination), iv) AMerican PREGNANcy/Child CohorT (AM-PREGNANT), and v) the IN-uTERO study aiming at identifying women at risk of having children with congenital malformations using causal and machine learning models (FRQS/Health Data Hub initiative, UMontreal and Université Paul Sabatier Toulouse 3). Dr. Bérard has published over 500 scientific papers, abstracts and patents, and has obtained over 37 million dollars in funding from CIHR, CFI, and FRQS as principal investigator. She recently received a Most Distinguished Scientist Award from the International Teratology Society for her work on antidepressants, maternal depression, and pregnancy; and a research career award from the Association of Faculties of Pharmacy of Canada. Anick Bérard is a member of the Scientific and Ethics Committee of the Cohorte Marianne in France aiming at identifying and quantifying epigenetics, environmental and lifestyle determinants of neuro-developmental disorders in children.